Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp > Its clear they are working on something

<< Previous

Bullboard Posts

Next >>

Comment by frontier2014on Feb 18, 2022 12:51pm

91 Views

Post# 34442384

RE:Its clear they are working on something

You keep repeating the same post under different headings....

instead of waiting for the carrots you need to be ready for the stick...at the end of the day we don't want to be like Chekhov:

I feel like a donkey, with a stick in my mouth and a carrot up my a$$. - Author: Anton Chekhov

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale